Your browser doesn't support javascript.
loading
Genetic variants of flavin-containing monooxygenase 3 (FMO3) derived from Japanese subjects with the trimethylaminuria phenotype and whole-genome sequence data from a large Japanese database.
Shimizu, Makiko; Yoda, Hiromi; Nakakuki, Komei; Saso, Aoi; Saito, Iria; Hishinuma, Eiji; Saito, Sakae; Hiratsuka, Masahiro; Yamazaki, Hiroshi.
Afiliación
  • Shimizu M; Showa Pharmaceutical University, Tokyo, Japan.
  • Yoda H; Showa Pharmaceutical University, Tokyo, Japan.
  • Nakakuki K; Showa Pharmaceutical University, Tokyo, Japan.
  • Saso A; Showa Pharmaceutical University, Tokyo, Japan.
  • Saito I; Showa Pharmaceutical University, Tokyo, Japan.
  • Hishinuma E; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Saito S; Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Hiratsuka M; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
  • Yamazaki H; Showa Pharmaceutical University, Tokyo, Japan. Electronic address: hyamazak@ac.shoyaku.ac.jp.
Drug Metab Pharmacokinet ; 34(5): 334-339, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31401033
Flavin-containing monooxygenase 3 (FMO3) is a polymorphic xenobiotic- and dietary compound-metabolizing enzyme associated with the genetic disorder trimethylaminuria. We phenotyped 428 Japanese subjects using traditional urinary phenotyping assays and identified two subjects with <20% FMO3 metabolic capacity. Both subjects had novel frameshift mutations. Proband 1 harbored a novel CC deletion resulting in p.[(Pro153Gln fs; Phe166Ter)] FMO3, which was in trans configuration with p.(Cys197Ter). Proband 2 harbored a novel T deletion resulting in p.[(Met211Arg fs; Val220Ter)] FMO3, which was in trans configuration with p.[(Val257Met; Met260Val)]. We also analyzed a new large Japanese database for novel single nucleotide substitutions of FMO3 and identified the following variants with very low frequencies (<∼0.1%): p.(Lys56Glu), p.(Ser112Asn), p.(Asn164Lys), p.(Gly191Cys), p.(Ile199Ser), p.(Pro248Thr), p.(Pro248Leu), p.(Asp286Tyr), and p.(Ala311Pro). Recombinant FMO3 proteins of the above and unanalyzed variants underwent kinetic analysis of their trimethylamine/benzydamine N-oxygenation activities. Gly191Cys, Ile199Ser, Asp286Tyr, and Ala311Pro variant FMO3 proteins exhibited severely decreased activities (Vmax/Km <5% of wild-type). Although these new variants were rare alleles in Japanese self-reported trimethylaminuria sufferers and in the large genomic database, we found that most Japanese individuals compound heterozygous or homozygous for any of these missense FMO3 variants or known severe mutations [e.g., p.(Cys197Ter)] had impaired FMO3-dependent N-oxygenation of malodorous trimethylamine.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oxigenasas / Bases de Datos Genéticas / Secuenciación Completa del Genoma / Errores Innatos del Metabolismo / Metilaminas Límite: Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Drug Metab Pharmacokinet Asunto de la revista: FARMACOLOGIA / METABOLISMO Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Oxigenasas / Bases de Datos Genéticas / Secuenciación Completa del Genoma / Errores Innatos del Metabolismo / Metilaminas Límite: Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Drug Metab Pharmacokinet Asunto de la revista: FARMACOLOGIA / METABOLISMO Año: 2019 Tipo del documento: Article País de afiliación: Japón